Tag: brca gene testing

CMS Cuts BRCA Price by 49% in Response to Competition

By Robert Michel, from the Volume XXI NO. 1 - January 13, 2014 issue

IN THE FINAL WEEKS OF 2013, the federal Centers for Medicare & Medicaid Services (CMS) announced that it would reduce the price it pays for the BRCA genetic test by 49%, to $1,438, effective on January 1, 2014.

For Myriad Genetics, Inc., this was not welcome news. Its share price fell by as much as 20%

View Article

Volume XXVI No. 5 – April 8, 2019

IT'S A FIRST FOR THE CLINICAL LAB INDUSTRY - and American industry as a whole. This issue exclusively reveals that after two years of testing, a lab has achieved the first revenue-generating flight of an unmanned drone in the U.S. Now, the lab's transport of supplies and specimens can safely bypass traffic regularly. Remarkably, the project has involved the cooperation of UPS and both the FAA and state regulators. Also, TDR reports that another government initiative, the National Correct Coding Initiative, has apparently gone awry. Labs could be harmed if they submit claims incorrectly based on the NCCI.

See the full table of contents

Tag: brca gene testing

Enter Your Login Credentials